Infinite® 200 PRO Offers Environmental Control for Cell-Based Applications
December 9, 2010
Männedorf, Switzerland - Tecan has launched a Gas Control Module (GCM™) for its Infinite 200 PRO multimode microplate reader, creating one of the most comprehensive solutions on the market for cell-based assays. Variations in environmental conditions can lead to inconsistent and unreliable data for cell-based optical studies, due changes in the pH and color of [...]
Ocimum Closes $8 million to Fuel Future Growth
December 9, 2010
Gaithersburg, Maryland, USA and Hyderabad, Andhra Pradesh, India - Ocimum Biosolutions today announced its growth plans after having closed funding worth $8 million from multiple sources, including founders and existing shareholders, in order to cater to the growing demand for its integrated genomic services and to provide unparalleled, hassle-free user experience by enhancing its RaaS [...]
December 9, 2010
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB). The limitations of traditional smear microscopy, along with the cost and long delays to receive [...]
CLC bio and Ingenuity Systems Integrate Pathway and Genomics Analysis Solutions
December 9, 2010
REDWOOD CITY, Calif. & AARHUS, Denmark - Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity’s pathway analysis software (IPA®), in order [...]
Techulon™ Names Nacalai as Glycofect™ Distributor for Japan
December 9, 2010
Biodegradable transfection reagents now available through distribution BLACKSBURG, Va. & SAN DIEGO - Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to [...]
December 9, 2010
Customers now receive copy number variation and structural variation results for cancer and normal genomes as part of the standard CGA™ Service offering MOUNTAIN VIEW, Calif. - Complete Genomics Inc. (NASDAQ: GNOM) announced today that its customers will now receive copy number variation (CNV) and structural variation (SV) results as part of the CGA™ Service. [...]
Taconic to Distribute Transposagen’s FatRatTM Obesity Model
December 9, 2010
World's only Mc4r Knockout Rat Model to be available through Taconic Hudson, New York - Taconic, a leading global provider of research models and services, and Transposagen Biopharmaceuticals, Inc. (Transposagen), the worldwide leader in genetically modified rats, announced today that they have entered into a non-exclusive marketing and distribution agreement. Under the agreement, Taconic will [...]
Harvard Bioscience Files Two Major Patents in Field of Regenerative Medicine
December 9, 2010
HOLLISTON, Mass. -Harvard Bioscience, Inc. ("Harvard Bioscience," or the "Company") (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors [...]
December 9, 2010
ALAMEDA, Calif. - BioTime Asia, Limited, a subsidiary of BioTime, Inc. (NYSE Amex:BTX) today announced an agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate™ cell lines to the medical and biological research communities in China, Taiwan, Hong Kong, and Macau. In addition to a wide array of human cell types, Genext will [...]
Life Technologies Prices Offering of Senior Notes
December 9, 2010
CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ:LIFE) announced today that it has priced the announced offering of $400 million aggregate principal amount of 3.50% Senior Notes due 2016 at an issue price of 99.840 percent of their face value and $400 million aggregate principal amount of 5.00% Senior Notes due 2021 at an issue price [...]